Question 1

Am I eligible for this trial based on my testosterone levels and health history?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study to Evaluate the Safety and Efficacy of Androxal™ Treatment in Men With Secondary Hypogonadism clinical trial (NCT00962637). Contact the study team or your healthcare provider for specific answers.

Question 2

How does Androxal compare to other treatments I might consider?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study to Evaluate the Safety and Efficacy of Androxal™ Treatment in Men With Secondary Hypogonadism clinical trial (NCT00962637). Contact the study team or your healthcare provider for specific answers.

Question 3

What side effects should I expect from Androxal or AndroGel?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study to Evaluate the Safety and Efficacy of Androxal™ Treatment in Men With Secondary Hypogonadism clinical trial (NCT00962637). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to visit the clinic during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study to Evaluate the Safety and Efficacy of Androxal™ Treatment in Men With Secondary Hypogonadism clinical trial (NCT00962637). Contact the study team or your healthcare provider for specific answers.

Question 5

What will happen if my testosterone levels do not improve with treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study to Evaluate the Safety and Efficacy of Androxal™ Treatment in Men With Secondary Hypogonadism clinical trial (NCT00962637). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any risks associated with participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study to Evaluate the Safety and Efficacy of Androxal™ Treatment in Men With Secondary Hypogonadism clinical trial (NCT00962637). Contact the study team or your healthcare provider for specific answers.

What this study is about